• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AIZU OLYMPUS CO., LTD. EVIS LUCERA DUODENOVIDEOSCOPE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AIZU OLYMPUS CO., LTD. EVIS LUCERA DUODENOVIDEOSCOPE Back to Search Results
Model Number TJF-260V
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Abdominal Pain (1685); Extreme Exhaustion (1843); Inflammation (1932); Urinary Frequency (2275); Weight Changes (2607); Pancreatitis (4481)
Event Date 04/27/2018
Event Type  Injury  
Event Description
Olympus medical systems corp.(omsc) received a literature titled "evaluation of a 12-mm diameter covered self-expandable end bare metal stent for malignant biliary obstruction." literature summary: this study aimed to evaluate the efficacy of a novel 12-mm-diameter covered, self-expandable end bare metal stent (12-mm cseems).A total of 99 patients with unresectable malignant distal biliary obstructions were enrolled.Univariate cox analysis demonstrated that risk of mortality was lower in patients with chemotherapy (hr, 0.610; 95 % ci, 0.4041 ¿ 0.92560; p = 0.020), multivariate cox hazard analysis demonstrated that risk of mortality was lower in the females (hr, 1.974; 95 % ci, 1.23762 ¿ 3.14849; p = 0.004).Recurrent biliary obstruction (rbo) was significantly lower in the 12-mm-cseems group than in 10-mm fcsems group.Early and late adverse events were significantly lower in 12-mm-cseems group than in 10-mm fcsems group.The 12-mm cseems showed a longer time to rbo (trbo) compared with the widely used 10-mm fcsems, with a similar incidence of adverse events.Therefore, this stent may be safe and effective for managing malignant distal biliary obstruction.Type of adverse events/number of patients: abdominal pain, cholangitis, cholecystitis, pancreatitis, hyperamylasemia, death.The death described in the literature is not being reported as it is unrelated to the olympus device.There is no report of any olympus device malfunction in any procedure described in this study.
 
Manufacturer Narrative
H6 code: urinary frequency, extreme exhaustion and weight changes are used to code hyperamylasemia amd inflammation is used for cholecystitis.The suspect device has not been returned to olympus for evaluation.The investigation is in process.The literature article is attached for additional information.Once the investigation has been completed, a supplemental report will be submitted with device evaluation results.
 
Event Description
Additional information received identified from the author stated that the olympus device did not cause or contribute to the adverse events described in the literature "evaluation of a 12-mm diameter covered self-expandable end bare metal stent for malignant biliary obstruction.".
 
Manufacturer Narrative
This supplemental report is being submitted to provide additional information obtained from the author regarding the reported event.New information added to the following.
 
Manufacturer Narrative
This report is being supplemented to provide additional information based on the legal manufacturer's final investigation.The device history record was unable to be reviewed for this device since the serial and/or lot number was not provided.However, olympus only releases products to market that meet all manufacturing specifications and final product release criteria.Based on the results of the investigation, the relationship between the device and the adverse event cannot be confirmed.There was no complaint reported on the subject device.There is no evidence of an olympus device malfunction.Therefore, the root cause cannot be determined.This supplemental report includes a correction to b3 to provide information that was inadvertently not included on the initial medwatch.Olympus will continue to monitor field performance for this device.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EVIS LUCERA DUODENOVIDEOSCOPE
Type of Device
DUODENOVIDEOSCOPE
Manufacturer (Section D)
AIZU OLYMPUS CO., LTD.
3-1-1 niiderakita
aizuwakamatsu-shi, fukushima 965-8 520
JA  965-8520
Manufacturer (Section G)
AIZU OLYMPUS CO., LTD.
3-1-1 niiderakita
aizuwakamatsu-shi, fukushima
Manufacturer Contact
todd brill
800 west park drive
westborough, MA 01581
5082077661
MDR Report Key17412388
MDR Text Key319954640
Report Number9610595-2023-10751
Device Sequence Number1
Product Code FDT
Combination Product (y/n)N
Reporter Country CodeJA
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,Study,Literature,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date 10/05/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberTJF-260V
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 07/03/2023
Initial Date FDA Received07/28/2023
Supplement Dates Manufacturer Received08/31/2023
10/05/2023
Supplement Dates FDA Received09/21/2023
10/05/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Reuse
Patient Sequence Number1
Patient Outcome(s) Other;
-
-